Vivactil versus Surmontil, both tricyclic antidepressants frequently prescribed for anxiety disorders, exhibit distinct pharmacological characteristics. Vivactil (its generic name), known for its potent suppressing effects on serotonin and norepinephrine reuptake, reveals a higher affinity for alpha-2 adrenergic receptors. This alters its potential